JNJ

Johnson & Johnson · Healthcare · Drug Manufacturers - General
$225.33
-5.47 (-2.37%)
Mkt Cap: 542.42B
Key Metrics
MetricValue
P/E RatioN/A
EV/EBITDAN/A
ROEN/A
Gross MarginN/A
Revenue GrowthN/A
FCF Yield3.9%
Dividend YieldN/A
Market Cap542.42B
Volume6.19M
Recent News
The Two Bucket Income Portfolio That Pays $5,000 a Month Plus a Cash Reserve to Survive 2008 Style Drawdowns
247wallst.com · 2026-05-30
How to Recession-Proof Your Retirement Income Before Summer 2026
fool.com · 2026-05-30
Johnson & Johnson (JNJ) Shares Fall 2.4% -- What GF Score of 87 Tells Investors
gurufocus.com · 2026-05-29
Johnson & Johnson (JNJ) Stock Slides as Market Rises: Facts to Know Before You Trade
zacks.com · 2026-05-29
RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) demonstrates prolonged clinical benefit as a first-line treatment for atypical EGFR-mutated non-small cell lung cancer
prnewswire.com · 2026-05-29
Want $1,400 in Passive Income? Invest $10,000 Into These 4 Dividend Stocks
247wallst.com · 2026-05-29

Unlock the Full Deep Scan

9 AI agents analyze JNJ across earnings, insider flow, macro conditions, corporate strategy, market microstructure, and price action.

Sign Up Free →